Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Mink Intersects 7.1 Meters of 0.44% Ni, 0.28% Cu, 0.06% Co in Massive Sulphide at Warren Property (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Cannara Biotech Inc V.LOVE


Primary Symbol: T.LOVE Alternate Symbol(s):  LOVFF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis Cannabis
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.


TSX:LOVE - Post by User

Cannara Biotech Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(132)
•••
  • WolfOakvilleX
Post by WolfOakvilleon Nov 25, 2025 11:18am
40 Views
Post# 36799855

2025 Q4 & Annuals FINS Review (3.75 / 5)

2025 Q4 & Annuals FINS Review (3.75 / 5)"Cannara Biotech has now had TWENTY consecutive quarters with year over year growth topping 20%."


Click for full review
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities